1190198-24-3

Usage

Uses

Used in Pharmaceutical Industry:
6-Bromobenzo[b]thiophene-2-carbonitrile serves as a crucial building block in the synthesis of a variety of pharmaceutical drugs. Its unique structure allows for the development of new medicinal compounds with potential therapeutic applications.
Used in Agrochemical Production:
6-Bromobenzo[b]thiophene-2-carbonitrile also acts as an intermediate in the production of agrochemicals, contributing to the creation of substances that are vital for agricultural applications, such as pesticides and herbicides.
Used in Material Science:
6-Bromobenzo[b]thiophene-2-carbonitrile has potential applications in the field of material science, particularly in the realm of organic semiconductors. It is being explored for its possible use in the development of electronic devices, showcasing its versatility beyond pharmaceutical and agrochemical applications.

Upstream product

• 19075-45-7 6-bromobenzo[b]thiophene-2-carbaldehyde 
• 57848-46-1 4-bromo-2-fluorobenzaldehyde 
• 374933-76-3 6-Brombenzothiophen-2-methanol 
• 105191-64-8 6-Brombenzothiophen-2-carbonsaeure-ethylester 
• 1190198-27-6 6-bromobenzo[b]thiophene-2-carboxamide 
• 105212-27-9 6-Brombenzothiophen-2-carbonylchlorid 
• 19075-58-2 6-bromo-1-benzothiophene-2-carboxylic acid 

Relevant academic research and scientific papers

Benzothiophene-flanked diketopyrrolopyrrole polymers: Impact of isomeric frameworks on carrier mobilities

Exploring new building blocks for solution-processable polymeric semiconductors has attracted much attention. We herein develop two isomeric benzothiophene-flanked diketopyrrolopyrrole polymers with different linkage positions and further systematically study the electronic structures, optical properties, and field-effect characteristics. Both polymers exhibit typical p-type transport characteristics with the highest mobility being up to 0.80 cm2 V-1 s-1. Our results suggest that the isomeric backbones for conjugated polymers greatly affect charge transport properties.

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

The present invention provides compounds of Formula I I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds act as diuretics and natriuretics and are valuable pharmaceutically active compounds for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension and conditions resulting from excessive salt and water retention.